WeVote
Log In

Bill

Bill

SB 1174

Relating to: incorporating awareness about fentanyl and the use of an opioid antagonist into school district educational goals. (FE)

2025-2026 Regular Session Introduced by Dianne Hesselbein and 3 co-sponsors

Wisconsin SB 1174 would require K-12 education to include fentanyl awareness and appropriate use of opioid antagonists in health curricula.

Fiscal estimate received
0
WeVote Research Nonpartisan
Bill Summary · SB 1174

Summary of Bill: SB 1174 (Wisconsin, 2025 Session)

Purpose and Intent

  • The bill aims to incorporate awareness about fentanyl and the use of an opioid antagonist into school district educational goals.
  • In broad terms, it seeks to ensure that K-12 education in Wisconsin includes instruction or goals related to fentanyl awareness and the appropriate use of opioid antagonists (e.g., naloxone) as part of student health and safety education.

Key Provisions and Changes

  • Incorporation into Educational Goals: School districts would be required to include objectives related to fentanyl awareness within their educational goals or standards.
  • Opioid Antagonist Education: The bill directs attention to the use of an opioid antagonist, likely focusing on when and how such medication should be used in emergency scenarios or as part of health education.
  • Scope: Applies to public school districts (and potentially other state-supported educational entities) in Wisconsin as part of their curriculum planning and health education standards.
  • Education Focus Areas: The bill implies a curriculum emphasis on recognizing signs of fentanyl exposure/overdose, risks associated with fentanyl, and practical information about emergency response and the role of opioid antagonists.

Affected Parties

  • Students: Benefit from enhanced health and safety education regarding fentanyl and opioid overdose prevention.
  • School Districts and Administrators: Responsible for updating educational goals and ensuring curriculum includes fentanyl awareness and antagonist-use content.
  • Educators: Will deliver or reinforce content related to drug awareness, overdose recognition, and emergency response training.
  • Parents and Guardians: May gain increased awareness of safety topics included in school curricula.

Procedural and Timeline Aspects

  • Introduction and Referral: SB 1174 was introduced on March 19, 2026, by Senators Hesselbein, Ratcliff, Roys, and Spreitzer, with initial cosponsors in the Assembly (Bare, Clancy, Joers, Sinicki, Subeck, Stubbs).
  • Committee Action: Referred to the Committee on Education for consideration.
  • Motion and Status: The bill had an action indicating consideration and a reading in committee. The record shows a later action (March 23, 2026) noting failure to pass pursuant to Senate Joint Resolution 1, suggesting a procedural barrier or a procedural motion affecting its advancement at that time.
  • Fiscal Note: A fiscal estimate was received on April 7, 2026, indicating that a financial analysis was prepared to assess costs or funding implications for implementing the bill’s provisions.

Potential Impact and Considerations

  • Educational Impact: If enacted, districts would need to adjust curricula to include fentanyl awareness and information about opioid antagonists, potentially increasing time and resources devoted to health education and safety training.
  • Costs: The fiscal note would address any costs related to curriculum development, teacher training, instructional materials, and potential naloxone availability in schools or related emergency preparedness measures.
  • Public Health Alignment: The bill aligns school programs with broader public health efforts to prevent opioid overdoses and increase community literacy about fentanyl risks.
  • Implementation Considerations: Successful adoption would require clear definitions of required content, alignment with existing health education standards, professional development for staff, and coordination with school safety protocols.

Note

  • As of the latest available action history, the bill did not advance past committee and faced a procedural outcome indicating it did not pass in the Senate at that time. The status could change with new legislative action or updates to the bill’s provisions.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.